New Product Newswire
FDA Approves Abuse-Deterrent 10 mg Oxycodone Hydrochloride for Severe Pain
The addition of a 10 mg oxycodone hydrochloride tablet improves dosing flexibility and precision.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
Abrysvo is the only RSV vaccine approved for use in this age group.
Gepotidacin NDA Under Priority Review by FDA for Uncomplicated UTI
Gepotidacin is a first-in-class oral antibiotic with a novel mechanism of action.
FDA Approves Ensifentrine, Novel Treatment for Chronic Obstructive Pulmonary Disease
On June 26, 2024, the FDA approved ensifentrine (Ohtuvayre) for the treatment of COPD.
FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications
The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.
